Thyroid carcinoma is rare among human malignancies (! 1%) but is the most frequent
endocrine cancer, accounting for about 5% of thyroid nodules (1). The latter are very …

Background: I-131 has been used in the therapy of well-differentiated thyroid cancer for over
50 years. Although the benefits and risks of I-131 remain issues of controversy and research …

Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the publication of the American Thyroid …

THYROID NODULES are a common clinical problem. Epidemiologic studies have shown
the prevalence of palpable thyroid nodules to be approximately 5% in women and 1% in …

Well under 15% of differentiated thyroid carcinoma (DTC) is diagnosed at≤ 18 years of age.
The population is heterogenous and the differences between prepubertal children and …

The term theranostics is the combination of a diagnostic tool that helps to define the right
therapeutic tool for specific disease. It signifies the “we know which sites require treatment …

Thyroid cancer typically has a good outcome following standard treatments, which include
surgery, radioactive iodine ablation and treatment with TSH-suppressive levothyroxine …

Целью этой книги является предоставление практическому врачу накопленной в мире
информации об эпидемиологии, этиологии, патогенезе, прикладной анатомии …

Simple Summary Differentiated thyroid cancer (DTC) is the most common endocrine
malignancy with a high incidence rate in females. The COVID-19 epidemic posed an …

Purpose: To evaluate the role of radioiodine and external radiotherapy treatment in papillary
thyroid carcinoma (PTC). Methods and Materials: This is a retrospective study of 842 …